CM
GOSS icon

Caption Management’s Gossamer Bio GOSS Stock Holding History

Caption Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-625
Closed -$16.4K – 1818
2026
Q1 		$16.4K Buy
625
+109
+21% +$13.7K ﹤0.01% 1459
2025
Q4 		$128K Sell
516
-29,609
-98% -$6.76M ﹤0.01% 1422
2025
Q3 		$6.34M Buy
30,125
+27,500
+1,048% +$4.85M 0.05% 406
2025
Q2 		$258K Buy
2,625
+125
+5% +$10.9K ﹤0.01% 1221
2025
Q1 		$220K Buy
+2,500
New +$231K ﹤0.01% 1253
2022
Q3 		– Sell
-1,234
Closed -$826K – 1631
2022
Q2 		$826K Buy
+1,234
New +$765K 0.01% 942
2021
Q1 		– Sell
-1,688
Closed -$1.3M – 1201
2020
Q4 		$1.3M Buy
1,688
+125
+8% +$98.5K 0.03% 550
2020
Q3 		$1.55M Buy
+1,563
New +$1.66M 0.04% 510
2020
Q2 		– Sell
-625
Closed -$507K – 1034
2020
Q1 		$507K Hold
625
– – 0.03% 541
2019
Q4 		$781K Sell
625
-1,011
-62% -$1.63M 0.03% 547
2019
Q3 		$2.2M Buy
+1,636
New +$2.6M 0.11% 221

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Caption Management's GOSS Position: Q2 2026 in Review

Caption Management sold out of Gossamer Bio (GOSS) in Q2 2026, closing a stake of 891 shares — an estimated $23.4K sold.

Caption Management first reported a position in GOSS in Q3 2019 and held it in 6 quarters. The position peaked at $4.23M in Q3 2019. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Caption Management reported no remaining Gossamer Bio position as of Q2 2026 after selling out during the quarter.
  • Caption Management sold 891 Gossamer Bio shares in Q2 2026, an estimated $23.4K.
  • Caption Management first reported a position in Gossamer Bio in Q3 2019 and held it in 6 quarters.
  • Caption Management's Gossamer Bio position peaked at $4.23M in Q3 2019.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.